Novanta Inc.
NOVT
Rang in Aktien
#3293
Operating globally, Novanta Inc. and its affiliated companies specialize in the... Operating globally, Novanta Inc. and its affiliated companies specialize in the development, production, and distribution of advanced photonics, vision, and precision motion components and sub-assemblies. These highly engineered solutions are supplied to Original Equipment Manufacturers (OEMs) across the medical and industrial sectors. Within its Photonics division, Novanta provides a suite of laser-driven technologies. These encompass systems for laser scanning, beam manipulation, and various laser types such as CO2, solid-state, ultrafast, and optical light engines. Their applications span critical areas like industrial manufacturing, precision measurement (metrology), advanced imaging in healthcare and biological research, DNA sequencing, and specialized medical laser treatments. The Vision segment delivers an array of medical-grade innovations. This portfolio comprises instruments like medical insufflators, pumps, and their associated consumables, alongside comprehensive visualization tools. It also features wireless communication systems, video recording devices, and integration platforms designed for operating theaters. Further offerings include optical data acquisition, machine vision systems, radio frequency identification (RFID) solutions, thermal recording devices, spectrometry equipment, and integrated touchscreen displays. Furthermore, the Precision Motion division specializes in supplying components such as optical and inductive encoders, high-precision motors, servo drives, and complete motion control systems. This segment also delivers integrated stepper motors, sophisticated robotic end-effectors, air bearings, and air bearing spindles. Novanta distributes its extensive product lines through various channels, including its dedicated direct sales team, value-added resellers, distribution partners, and system integrators. These offerings are available under well-known brand names such as Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, Celera Motion, MicroE, Zettlex, Applimotion, Ingenia, and Westwind. Founded in 1968, the company operated as GSI Group, Inc. until its rebranding to Novanta Inc. in May 2016. Its corporate headquarters are located in Bedford, Massachusetts.
Aktienkurs
$139.98
Zuletzt synchronisiert: 2026-10-21
Marktkapitalisierung
$5.29B
Veränderung (1 Tag)
3.24%
Veränderung (1 Jahr)
20.18%
Land
US
Handel Novanta Inc. (NOVT)
Kategorie
Technology
KGV für Novanta Inc. (NOVT)
KGV zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Novanta Inc. beträgt das aktuelle P/E-Verhältnis (TTM) 0. Am Ende des Jahres 2026 hatte das Unternehmen ein P/E von 0.
P/E-Verlaufsdaten für Novanta Inc. von 2001 bis 2026
P/E-Verhältnis am Ende jedes Jahres
| Jahr | KGV | ändert |
|---|---|---|
| 2025 | 80.95 | -5.54% |
| 2024 | 85.70 | 3.46% |
| 2023 | 82.83 | 26.62% |
| 2022 | 65.41 | -47.25% |
| 2021 | 124.01 | 32.88% |
| 2020 | 93.32 | 22.82% |
| 2019 | 75.98 | 69.65% |
| 2018 | 44.79 | 54.50% |
| 2017 | 28.99 | -12.45% |
| 2016 | 33.11 | 150.40% |
| 2015 | 13.22 | -163.42% |
| 2014 | -20.85 | -139.79% |
| 2013 | 52.40 | 250.01% |
| 2012 | 14.97 | 26.63% |
| 2011 | 11.82 | -103.24% |
| 2010 | -365.03 | 62,577.39% |
| 2009 | -0.58 | 382.92% |
| 2008 | -0.12 | -100.47% |
| 2007 | 25.83 | 38.34% |
| 2006 | 18.67 | 95.49% |
| 2005 | 9.55 | 463.27% |
| 2004 | 1.70 | -101.88% |
| 2003 | -90.14 | 919.23% |
| 2002 | -8.84 | -61.97% |
| 2001 | -23.25 | 0.00% |
P/E-Verhältnis für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | P/E Ratio | P/E Ratio-Differenz | Land |
|---|---|---|---|
| 37.71 | - |
US
|
|
| 14.94 | - |
JP
|
|
| 49.65 | - |
TW
|
|
| 61.05 | - |
US
|
|
| 16.11 | - |
TW
|
Wie liest man ein P/E Ratio?
Das Kurs-Gewinn-Verhältnis (P/E Ratio) misst das Verhältnis zwischen dem Aktienkurs eines Unternehmens und seinem Gewinn pro Aktie.
Ein niedriges, aber positives P/E weist auf ein Unternehmen hin, das hohe Gewinne im Verhältnis zur aktuellen Bewertung erzielt und möglicherweise unterbewertet ist. Ein Unternehmen mit einem hohen negativen (nahe 0) P/E macht hohe Verluste im Verhältnis zur Bewertung.
Unternehmen mit einem P/E über 30 oder negativ werden allgemein als "Wachstumsaktien" betrachtet, was bedeutet, dass Investoren erwarten, dass das Unternehmen in Zukunft wächst oder profitabel wird.
Unternehmen mit einem positiven P/E unter 10 gelten im Allgemeinen als "Value-Aktien", was bedeutet, dass das Unternehmen bereits sehr profitabel ist, aber in Zukunft wahrscheinlich kein starkes Wachstum aufweisen wird.